文献速递关节外科

全膝关节置换术后大剂量阿片类药物处方的风险患者

Patients at Risk: Large Opioid Prescriptions After Total Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2017-03-02

该回顾性研究纳入105例初次全膝关节置换术且随访至少1年的患者,排除双侧置换、术前阿片类药物使用或术后3个月内再手术者,分析出院阿片类药物处方量与申请续方的关联。结果显示总处方吗啡等效剂量平均1405±616 mg(范围273-3250 mg),需要续方者与无需续方者的总处方剂量、每日处方剂量及术前膝关节协会评分均无显著差异。作者认为应避免过度阿片类药物处方。

要点

  • 全膝关节置换术后阿片类药物处方总量变异大,总吗啡等效剂量范围273-3250 mg。
  • 需要续方者与无需续方者的总处方吗啡等效剂量无显著差异(1521±624 vs 1349±609 mg;P = .1)。
  • 大处方(≥1400 mg)与小处方续方率无差异,过度处方不减少续方且带来滥用风险。

核心结论

  • 全膝关节置换术后阿片类药物处方量变异很大,总吗啡等效剂量范围为273-3250 mg。
  • 大处方(≥1400 mg)与小处方的续方率无差异。
  • 作者认为应避免过度阿片类药物处方,因其不减少续方次数且带来滥用风险。

研究设计与样本

  • 回顾性综述,纳入105例初次全膝关节置换术,随访至少1年。
  • 排除标准包括双侧全膝关节置换术、术前阿片类药物使用或术后前3个月内再手术。
  • 收集数据包括阿片类药物续方、膝关节协会评分及处方的总与每日吗啡等效剂量。

主要发现

  • 患者最常出院带药为羟考酮(90%)、氢吗啡酮(5%)和氢可酮/对乙酰氨基酚(1%)。
  • 平均总处方吗啡等效剂量为1405±616 mg(范围273-3250 mg)。
  • 需要续方者与无需续方者的总处方吗啡等效剂量无显著差异(1521±624 vs 1349±609 mg;P = .1)。
  • 需要续方者与无需续方者的每日处方吗啡等效剂量无显著差异(153±10 vs 155±7 mg;P = .8)。
  • 需要续方者与无需续方者的术前膝关节协会评分无显著差异(63±16 vs 60±13;P = .3)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Opioids are an effective, and often necessary, treatment of postoperative pain after total knee arthroplasty (TKA). However, it is often difficult to know how much medication patients will need after discharge. The purpose of this study was to determine if patients discharged with greater quantities of opioids after TKA are more likely to request refills. METHODS: This is a retrospective review of 105 primary TKAs performed with at least 1 year of follow-up. Exclusion criteria included bilateral TKA, preoperative opioid use, or reoperation within the first 3 months. Data collected included opioid refills, Knee Society Score, and total and daily morphine equivalent dose (MED) prescribed. RESULTS: Patients were most commonly discharged on oxycodone (90%), hydromorphone (5%), and hydrocodone/acetaminophen (1%). The average total prescribed MED was 1405 ± 616 mg (range, 273-3250 mg). Patients requiring refills did not differ in the total prescribed MED (1521 ± 624 vs 1349 ± 609 mg; P = .1), daily prescribed MED (153 ± 10 vs 155 ± 7 mg; P = .8), or preoperative Knee Society Score (63 ± 16 vs 60 ± 13; P = .3). Average follow-up time was 2.4 ± 0.5 years. CONCLUSION: The quantity of opioids prescribed after TKA varied widely, ranging from a total MED of 273-3250 mg. The refill rate did not differ between large prescriptions (≥1400 mg) and smaller prescriptions. Excessive opioid prescriptions should be avoided as they did not decrease the number of refills and pose the risk of divergence and subsequent abuse.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Hernandez NM, Parry JA, Taunton MJ, et al. Patients at Risk: Large Opioid Prescriptions After Total Knee Arthroplasty. J Arthroplasty. 2017. PMID: 28392133. doi:10.1016/j.arth.2017.02.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。